All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Filed	Company	Filing	Accession
2023-01-05	Oyster Point Pharma, Inc. ShelfEffectiveCIK 1720725	EFFECTDeclared effective	9999999995-23-000038
2020-12-18	Oyster Point Pharma, Inc. ShelfEffectiveCIK 1720725	424B5Shelf takedown	0001193125-20-321531
2020-11-16	Oyster Point Pharma, Inc. ShelfEffectiveCIK 1720725	EFFECTDeclared effective	9999999995-20-003193
2020-11-05	Oyster Point Pharma, Inc. ShelfEffectiveCIK 1720725	S-3Shelf registered	0001193125-20-286956
2020-05-18	Oyster Point Pharma, Inc. Registered companyFinal prospectusCIK 1720725	424B4Final prospectus	0001193125-20-144236
2020-05-14	Oyster Point Pharma, Inc. Registered companyFinal prospectusCIK 1720725	EFFECTDeclared effective	9999999995-20-001166
2020-05-14	Oyster Point Pharma, Inc. Registered companyFinal prospectusCIK 1720725	S-1/AAmendment	0001193125-20-142919
2020-05-12	Oyster Point Pharma, Inc. Registered companyFinal prospectusCIK 1720725	S-1Registration filed	0001193125-20-140387
2020-04-27	Oyster Point Pharma, Inc. CIK 1720725	DRSDraft made public	0000950123-20-003618
2019-10-31	Oyster Point Pharma, Inc. IPOFinal prospectusCIK 1720725	424B4Final prospectus	0001193125-19-280598
2019-10-30	Oyster Point Pharma, Inc. IPOFinal prospectusCIK 1720725	EFFECTDeclared effective	9999999995-19-002429
2019-10-21	Oyster Point Pharma, Inc. IPOFinal prospectusCIK 1720725	S-1/AAmendment	0001193125-19-270374
2019-10-15	Oyster Point Pharma, Inc. IPOFinal prospectusCIK 1720725	S-1/AAmendment	0001193125-19-267294
2019-10-04	Oyster Point Pharma, Inc. IPOFinal prospectusCIK 1720725	S-1Registration filed	0001193125-19-262771
2019-07-25	Oyster Point Pharma, Inc. CIK 1720725	DRSDraft made public	0000950123-19-006616